39 related articles for article (PubMed ID: 24921956)
1. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
2. Current treatment options: relief of symptoms and ultimate recovery.
Kennedy SH
Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():22-6. PubMed ID: 24931540
[TBL] [Abstract][Full Text] [Related]
3. [Severe forms of depression: the efficacy of escitalopram].
Spadone C
Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
[TBL] [Abstract][Full Text] [Related]
4. [Treatment adherence in the recurrent depressive disorders].
Spadone C
Encephale; 2002; 28(3 Pt 1):255-9. PubMed ID: 12091787
[TBL] [Abstract][Full Text] [Related]
5. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram for the treatment of major depression and anxiety disorders.
Höschl C; Svestka J
Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657
[TBL] [Abstract][Full Text] [Related]
7. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
8. Serotonin, sertraline and depression.
Montgomery S
J Psychopharmacol; 1995 Jan; 9(2 Suppl):179-84. PubMed ID: 22297236
[TBL] [Abstract][Full Text] [Related]
9. The management of depression: An international naturalistic survey.
Lecrubier Y; Bahk WM; De Matos J; Briley M
Int J Psychiatry Clin Pract; 2008; 12(4):285-91. PubMed ID: 24937715
[TBL] [Abstract][Full Text] [Related]
10. [Suicide Risk Assessment in the Clinical Practice Guidelines for the Diagnosis and Management of Depression in Colombia].
Gómez Restrepo C; Bohórquez Peñaranda AP; Gil Lemus LM; Jaramillo LE; García Valencia J; Bravo Narváez E; de la Hoz Bradford AM; Palacio C
Rev Colomb Psiquiatr; 2013; 43 Suppl 1():3-11. PubMed ID: 26574108
[TBL] [Abstract][Full Text] [Related]
11. Raising More Than Moods: Escitalopram-Associated Priapism.
Budzak LM; Yasin W; Mulhall J
Fed Pract; 2019 Feb; 36(2):94-96. PubMed ID: 30867630
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant adherence after psychiatric hospitalization among VA patients with depression.
Zivin K; Ganoczy D; Pfeiffer PN; Miller EM; Valenstein M
Adm Policy Ment Health; 2009 Nov; 36(6):406-15. PubMed ID: 19609666
[TBL] [Abstract][Full Text] [Related]
13. Guidelines in major depressive disorder, and their limitations.
Montgomery SA
Int J Psychiatry Clin Pract; 2006; 10 Suppl 3():3-9. PubMed ID: 24921956
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
15. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
16. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
